Expert solutions for oral and parenteral product development

based on proprietary nanotechnology

We are a specialised product development company dedicated to developing a pipeline of enhanced versions of existing drug products, and providing services to enable pre-clinical and clinical  stage formulations for our clients NCEs or branded established drugs.

leon-nanodrugs offers access to the next generation of nano-formulated drugs with meaningful differentiation and added patient benefits.

We specialize in improving the bioavailability of poorly water soluble drugs by using leon’s proprietary MJR® Technology platform to create either polymeric or crystalline nanoparticles.

leons meaningful differentiation…

  • Improved bioavailability, Faster onset of action, Dose reduction resulting in lower drug exposure, Improved stability
  • Extension of life cycle, Earlier to market
  • Lower pill burden, eliminate food effect, increased patient compliance
  • 3 year goal from concept to FDA / EMA, submission due to abbreviated regulatory pathway, e.g. 505(b)2, Hybrid Application

Whats´s new with LEON take a look at LEONs Technology come and meet LEON

By closing this message, you consent to our cookies on this device in accordance with our cookie policy. Detailed information about the use of cookies on this website and how you can manage or withdraw your consent at any time can be found in our privacy policy.

Read more